BSE Live
Sep 09, 10:39Prev. Close
881.05
Open Price
881.30
Bid Price (Qty.)
894.45 (4)
Offer Price (Qty.)
895.50 (10)
NSE Live
Sep 09, 10:39Prev. Close
881.60
Open Price
889.00
Bid Price (Qty.)
894.65 (155)
Offer Price (Qty.)
894.80 (26)
Balance Sheet of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 45.32 | 45.31 | 45.31 | 45.56 | 0.25 | |
Total Share Capital | 45.32 | 45.31 | 45.31 | 45.56 | 0.25 | |
Reserves and Surplus | 1,798.55 | 1,576.15 | 1,393.27 | 1,238.71 | -0.02 | |
Total Reserves and Surplus | 1,798.55 | 1,576.15 | 1,393.27 | 1,238.71 | -0.02 | |
Total Shareholders Funds | 1,843.87 | 1,621.46 | 1,438.58 | 1,284.28 | 0.23 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 103.56 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 119.69 | 97.93 | 68.85 | 59.35 | 0.00 | |
Other Long Term Liabilities | 27.07 | 16.66 | 0.53 | 1.53 | 0.02 | |
Long Term Provisions | 7.09 | 5.28 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 257.40 | 119.87 | 69.38 | 60.88 | 0.02 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 291.30 | 250.80 | 206.71 | 324.62 | 0.00 | |
Trade Payables | 248.97 | 254.79 | 219.75 | 131.61 | 0.00 | |
Other Current Liabilities | 71.52 | 43.76 | 17.63 | 16.48 | 0.00 | |
Short Term Provisions | 10.54 | 6.24 | 11.21 | 8.96 | 0.00 | |
Total Current Liabilities | 622.33 | 555.58 | 455.31 | 481.67 | 0.00 | |
Total Capital And Liabilities | 2,723.61 | 2,296.91 | 1,963.27 | 1,826.83 | 0.25 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,096.54 | 936.47 | 848.21 | 700.89 | 0.00 | |
Intangible Assets | 30.55 | 16.86 | 0.18 | 0.23 | 0.00 | |
Capital Work-In-Progress | 300.92 | 78.50 | 62.23 | 165.23 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,428.02 | 1,090.25 | 950.30 | 888.48 | 0.00 | |
Non-Current Investments | 41.15 | 43.83 | 42.67 | 39.87 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 7.30 | 5.85 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 34.33 | 22.92 | 11.33 | 8.21 | 0.00 | |
Total Non-Current Assets | 1,510.81 | 1,162.85 | 1,004.30 | 936.56 | 0.00 | |
CURRENT ASSETS | ||||||
Current Investments | 15.88 | 17.83 | 0.00 | 0.00 | 0.00 | |
Inventories | 544.22 | 582.15 | 537.68 | 444.38 | 0.00 | |
Trade Receivables | 552.59 | 448.82 | 361.61 | 304.22 | 0.00 | |
Cash And Cash Equivalents | 3.52 | 4.43 | 13.18 | 56.50 | 0.25 | |
Short Term Loans And Advances | 0.76 | 0.93 | 5.85 | 4.78 | 0.00 | |
OtherCurrentAssets | 95.83 | 79.90 | 40.65 | 80.40 | 0.00 | |
Total Current Assets | 1,212.80 | 1,134.06 | 958.98 | 890.27 | 0.25 | |
Total Assets | 2,723.61 | 2,296.91 | 1,963.27 | 1,826.83 | 0.25 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 29.03 | 20.86 | 19.40 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 195.92 | 152.83 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.64 | 1.46 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 258.52 | 9.49 | 4.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 741.93 | 623.13 | 470.57 | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 30.32 | 29.16 | 26.35 | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
28.02.2025
18.02.2025
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
06.02.2025
AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y
06.02.2025
AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y